{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T11:38:23Z","timestamp":1784029103889,"version":"3.55.0"},"reference-count":203,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"3771","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Science"],"published-print":{"date-parts":[[1967,4,7]]},"abstract":"<jats:p>The studies discussed here have shown a fairly consistent relationship between the effects of drugs on biogenic amines, particularly norepinephrine, and affective or behavioral states. Those drugs which cause depletion and inactivation of norepinephrine centrally produce sedation or depression, while drugs which increase or potentiate brain norepinephrine are associated with behavioral stimulation or excitement and generally have an antidepressant effect in man. From these findings, a number of investigators have formulated the concept, designated the catecholamine hypothesis of affective disorders, that some, if not all, depressions may be associated with a relative deficiency of norepinephrine at functionally important adrenergic receptor sites in the brain, whereas elations may be associated with an excess of such amines.<\/jats:p><jats:p>It is not possible either to confirm or to reject this hypothesis on the basis of currently available clinical data. Although there does appear to be a fairly consistent relationship between the effects of pharmacological agents on norepinephrine metabolism and on affective state, a rigorous extrapolation from pharmacological studies to pathophysiology cannot be made. Confirmation of this hypothesis must ultimately depend upon direct demonstration of the biochemical abnormality in the naturally occurring illness.<\/jats:p><jats:p>It should be emphasized, however, that the demonstration of such a biochemical abnormality would not necessarily imply a genetic or constitutional, rather than an environmental or psychological, etiology of depression. Whereas specific genetic factors may be of importance in the etiology of some, and possibly all, depressions, it is equally conceivable that early experiences of the infant or child may cause enduring biochemical changes and that these may predispose some individuals to depressions in adulthood.<\/jats:p><jats:p>It is not likely that changes in the metabolism of the biogenic amines alone will account for the complex phenomena of normal or pathological affect. Whereas the effects of these amines at particular sites in the brain may be of crucial importance in the regulation of affect, any comprehensive formulation of the physiology of affective state will have to include many other concomitant biochemical, physiological, and psychological factors. Although in this review of the relationship of biogenic amines to affective state relatively little has been said concerning the intricate set of environmental and psychological determinants of emotion, the importance of these factors must be stressed.<\/jats:p><jats:p>The normally occurring alterations in affective state induced by environmental events is well known to all, from personal experience. The interactions between such environmental determinants of affect, various physiological factors, and the complexity of psychological determinants, including cognitive factors derived from the individual's remote and immediate past experiences, have received only limited study under adequately controlled conditions. It may be anticipated, however, that this will prove to be a particularly fruitful area for future research, for only within such a multifactorial framework may one expect to understand fully the relationship of the biogenic amines to emotional state.<\/jats:p>","DOI":"10.1126\/science.156.3771.21","type":"journal-article","created":{"date-parts":[[2006,10,5]],"date-time":"2006-10-05T11:08:12Z","timestamp":1160046492000},"page":"21-30","source":"Crossref","is-referenced-by-count":695,"title":["Biogenic Amines and Emotion"],"prefix":"10.1126","volume":"156","author":[{"given":"Joseph J.","family":"Schildkraut","sequence":"first","affiliation":[{"name":"Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seymour S.","family":"Kety","sequence":"additional","affiliation":[{"name":"Laboratory of Clinical Science, National Institute of Mental Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_2_1_1_1","unstructured":"Acheson G. H. Second Symposium on Catecholamines (1966)."},{"key":"e_1_2_1_2_1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/jama.1955.02960260011004","volume":"159","year":"1955","unstructured":"ACHOR, R. W. R., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 159: 841 (1955).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_3_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00005053-196503000-00005","volume":"140","year":"1965","unstructured":"ALLEGRANZA, A, URINARY-EXCRETION OF 5-HYDROXYINDOLEACETIC, HOMOVANILLIC AND VANILMANDELIC ACIDS IN SCHIZOPHRENICS TAKING RESERPINE AND CHLORPROMAZINE, JOURNAL OF NERVOUS AND MENTAL DISEASE 140: 207 (1965).","journal-title":"JOURNAL OF NERVOUS AND MENTAL DISEASE"},{"key":"e_1_2_1_4_1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0024-3205(64)90221-8","volume":"3","year":"1964","unstructured":"ANDEN, N.E., CORRELATION BETWEEN NORADRENALINE UPTAKE AND ADRENERGIC NERVE FUNCTION AFTER RESERPINE TREATMENT, LIFE SCIENCES 3: 19 (1964).","journal-title":"LIFE SCIENCES"},{"key":"e_1_2_1_5_1","first-page":"133","volume":"4","year":"1962","unstructured":"APRISON, M. H., RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY 4: 133 (1962).","journal-title":"RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY"},{"key":"e_1_2_1_6_1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/1861050a0","volume":"186","year":"1960","unstructured":"ASHCROFT, G.W., 5-HYDROXYINDOLES IN HUMAN CEREBROSPINAL FLUIDS, NATURE 186: 1050 (1960).","journal-title":"NATURE"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/00006842-195309000-00007","volume":"15","year":"1953","unstructured":"AX, A.F., THE PHYSIOLOGICAL DIFFERENTIATION BETWEEN FEAR AND ANGER IN HUMANS, PSYCHOSOMATIC MEDICINE 15: 433 (1953).","journal-title":"PSYCHOSOMATIC MEDICINE"},{"key":"e_1_2_1_8_1","first-page":"5","year":"1963","unstructured":"Axelrod, J., The Clinical Chemistry of Monoamines: 5 (1963).","journal-title":"The Clinical Chemistry of Monoamines"},{"key":"e_1_2_1_9_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0079-6123(08)60119-3","volume":"8","year":"1964","unstructured":"AXELROD, J, Progress in Brain Research 8: 81 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_10_1","first-page":"354","volume":"58","year":"1958","unstructured":"AYD, F.J., NY STATE J MED 58: 354 (1958).","journal-title":"NY STATE J MED"},{"key":"e_1_2_1_11_1","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archneurpsyc.1956.02330250100015","volume":"76","year":"1956","unstructured":"BASOWITZ, H, ANXIETY AND PERFORMANCE CHANGES WITH A MINIMAL DOSE OF EPINEPHRINE, ARCHIVES OF NEUROLOGY AND PSYCHIATRY 76: 98 (1956).","journal-title":"ARCHIVES OF NEUROLOGY AND PSYCHIATRY"},{"key":"e_1_2_1_12_1","unstructured":"BERGSMAN A ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA 133 (1959)."},{"key":"e_1_2_1_13_1","first-page":"1","year":"1959","unstructured":"BERGSMAN, A, ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA 133: 1 (1959).","journal-title":"ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA"},{"key":"e_1_2_1_14_1","first-page":"525","volume":"27","year":"1960","unstructured":"BERNSTEIN, S, JOURNAL OF THE MOUNT SINAI HOSPITAL 27: 525 (1960).","journal-title":"JOURNAL OF THE MOUNT SINAI HOSPITAL"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF00596980"},{"key":"e_1_2_1_16_1","unstructured":"Blaschko H. 5-Hydroxytryptamine (1958)."},{"key":"e_1_2_1_17_1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/00005053-196412000-00009","volume":"139","year":"1964","unstructured":"BREGGIN, P.R., THE PSYCHOPHYSIOLOGY OF ANXIETY - WITH A REVIEW OF THE LITERATURE CONCERNING ADRENALINE, JOURNAL OF NERVOUS AND MENTAL DISEASE 139: 558 (1964).","journal-title":"JOURNAL OF NERVOUS AND MENTAL DISEASE"},{"key":"e_1_2_1_18_1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1749-6632.1957.tb40753.x","volume":"66","year":"1957","unstructured":"BRODIE, B.B., A CONCEPT FOR A ROLE OF SEROTONIN AND NOREPINEPHRINE AS CHEMICAL MEDIATORS IN THE BRAIN, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 66: 631 (1957).","journal-title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES"},{"key":"e_1_2_1_19_1","first-page":"250","volume":"129","year":"1960","unstructured":"BRODIE, B.B., EVIDENCE THAT TRANQUILIZING ACTION OF RESERPINE IS ASSOCIATED WITH CHANGE IN BRAIN SEROTONIN AND NOT IN BRAIN NOREPINEPHRINE - EFFECTS OF RESERPINE, RAUNESCINE, BENZOQUINOLIZINES, DIMETHYL-AMINOBENZOYL METHYLRESERPATE, AND STRESS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 129: 250 (1960).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_20_1","first-page":"340","volume":"152","year":"1966","unstructured":"BRODIE, B.B., ROLE OF BRAIN SEROTONIN IN MECHANISM OF CENTRAL ACTION OF RESERPINE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 152: 340 (1966).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_21_1","unstructured":"Brodie B. B. The Scientific Basis of Drug Therapy in Psychiatry (1965)."},{"key":"e_1_2_1_22_1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","volume":"2","year":"1949","unstructured":"CADE, F, MEDICAL JOURNAL OF AUSTRALIA 2: 349 (1949).","journal-title":"MEDICAL JOURNAL OF AUSTRALIA"},{"key":"e_1_2_1_23_1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2307\/1415404","volume":"39","year":"1927","unstructured":"CANNON, W.B., The James-Lange theory of emotions: A critical examination and an alternative theory, AMERICAN JOURNAL OF PSYCHOLOGY 39: 106 (1927).","journal-title":"AMERICAN JOURNAL OF PSYCHOLOGY"},{"key":"e_1_2_1_24_1","unstructured":"Cannon W. B. Bodily Changes in Pain Hunger Fear and Rage (1915)."},{"key":"e_1_2_1_25_1","doi-asserted-by":"crossref","first-page":"300","DOI":"10.2307\/1414829","volume":"44","year":"1932","unstructured":"CANTRIL, H, Emotional effects produced by the injection of adrenalin, AMERICAN JOURNAL OF PSYCHOLOGY 44: 300 (1932).","journal-title":"AMERICAN JOURNAL OF PSYCHOLOGY"},{"key":"e_1_2_1_26_1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1748-1716.1963.tb02763.x","volume":"59","year":"1963","unstructured":"CARLSSON, A, TIME CORRELATION BETWEEN EFFECTS OF RESERPINE ON BEHAVIOUR AND STORAGE MECHANISM FOR ARYLALKYLAMINES, ACTA PHYSIOLOGICA SCANDINAVICA 59: 474 (1963).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_27_1","unstructured":"Carlsson A. Adrenergic Mechanisms (1960)."},{"key":"e_1_2_1_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/1801200a0"},{"key":"e_1_2_1_29_1","first-page":"417","volume":"2","year":"1961","unstructured":"CARLSSON, A, NEUROPSYCHOPHARMACOLOGY 2: 417 (1961).","journal-title":"NEUROPSYCHOPHARMACOLOGY"},{"key":"e_1_2_1_30_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0079-6123(08)60110-7","volume":"8","year":"1964","unstructured":"CARLSSON, A, Progress in Brain Research 8: 9 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_31_1","first-page":"363","year":"1957","unstructured":"Carlsson, A., Psychotropic Drugs: 363 (1957).","journal-title":"Psychotropic Drugs"},{"key":"e_1_2_1_32_1","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/BF00404124","volume":"2","year":"1961","unstructured":"CARLTON, P.L., POTENTIATION OF THE BEHAVIORAL-EFFECTS OF AMPHETAMINE BY IMIPRAMINE, PSYCHOPHARMACOLOGIA 2: 364 (1961).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_33_1","first-page":"453","volume":"119","year":"1957","unstructured":"CHESSIN, M.E., MODIFICATIONS OF THE PHARMACOLOGY OF RESERPINE AND SEROTONIN BY IPRONIAZID, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 119: 453 (1957).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_34_1","first-page":"154","volume":"4","year":"1962","unstructured":"COCHRAN, B, RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY 4: 154 (1962).","journal-title":"RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY"},{"key":"e_1_2_1_35_1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7326\/0003-4819-56-6-960","volume":"56","year":"1962","unstructured":"COHEN, R.A., METABOLISM OF CATECHOLAMINES (CLINICAL IMPLICATIONS) - COMBINED CLINICAL STAFF CONFERENCE OF NATIONAL INSTITUTES OF HEALTH, ANNALS OF INTERNAL MEDICINE 56: 960 (1962).","journal-title":"ANNALS OF INTERNAL MEDICINE"},{"key":"e_1_2_1_36_1","first-page":"483","volume":"11","year":"1959","unstructured":"COHEN, R.A., PHARMACOL REV 11: 483 (1959).","journal-title":"PHARMACOL REV"},{"key":"e_1_2_1_37_1","first-page":"448","volume":"190","year":"1964","unstructured":"COLE, J. O., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 190: 448 (1964).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_38_1","first-page":"539","volume":"16","year":"1961","unstructured":"COLE, J.O., PROGRESS IN NEUROLOGY AND PSYCHIATRY 16: 539 (1961).","journal-title":"PROGRESS IN NEUROLOGY AND PSYCHIATRY"},{"key":"e_1_2_1_39_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1192\/bjp.111.470.105","volume":"111","year":"1965","unstructured":"COPPEN, A, CHANGES IN 5-HYDROXYTRYPTOPHAN METABOLISM IN DEPRESSION, BRITISH JOURNAL OF PSYCHIATRY 111: 105 (1965).","journal-title":"BRITISH JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_40_1","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1192\/bjp.111.479.993","volume":"111","year":"1965","unstructured":"COPPEN, A, TRYPTAMINE METABOLISM IN DEPRESSION, BRITISH JOURNAL OF PSYCHIATRY 111: 993 (1965).","journal-title":"BRITISH JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_41_1","first-page":"79","volume":"1","year":"1963","unstructured":"COPPEN, A, POTENTIATION OF ANTIDEPRESSIVE EFFECT OF A MONOAMINE-OXIDASE INHIBITOR BY TRYPTOPHAN, LANCET 1: 79 (1963).","journal-title":"LANCET"},{"key":"e_1_2_1_42_1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0079-6123(08)60125-9","volume":"8","year":"1964","unstructured":"COSTA, E, Progress in Brain Research 8: 168 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_43_1","first-page":"142","volume":"8","year":"1957","unstructured":"CRANE, G.E., PSYCHIATRIC RESEARCH REPORTS 8: 142 (1957).","journal-title":"PSYCHIATRIC RESEARCH REPORTS"},{"key":"e_1_2_1_44_1","unstructured":"Crawford T. B. B. 5-Hydroxytryptamine (1958)."},{"key":"e_1_2_1_45_1","unstructured":"Crossland J. The Clinical Chemistry of Monoamines (1963)."},{"key":"e_1_2_1_46_1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/0022-3999(60)90009-X","volume":"4","year":"1960","unstructured":"CURTIS, G.C., THE RELATIONSHIP BETWEEN AFFECT AND THE EXCRETION OF ADRENALINE, NORADRENALINE, AND 17-HYDROXYCORTICOSTEROIDS, JOURNAL OF PSYCHOSOMATIC RESEARCH 4: 176 (1960).","journal-title":"JOURNAL OF PSYCHOSOMATIC RESEARCH"},{"key":"e_1_2_1_47_1","unstructured":"de Ajuriaguerra J. Monoamines et Systeme Nerveux Central (1962)."},{"key":"e_1_2_1_48_1","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/BF02189076","volume":"38","year":"1960","unstructured":"DEGKWITZ, R, UBER DIE WIRKUNGEN DES L-DOPA BEIM MENSCHEN UND DEREN BEEINFLUSSUNG DURCH RESERPIN, CHLORPROMAZIN, IPRONIAZID UND VITAMIN-B6, KLINISCHE WOCHENSCHRIFT 38: 120 (1960).","journal-title":"KLINISCHE WOCHENSCHRIFT"},{"key":"e_1_2_1_49_1","unstructured":"Dick P. Antidepressant Drugs (1967)."},{"key":"e_1_2_1_50_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0033-3182(65)72335-9","volume":"6","year":"1965","unstructured":"DUNLOP, E, THE RELATIONSHIP BETWEEN MAO INHIBITION AND IMPROVEMENT OF DEPRESSION - PRELIMINARY-RESULTS WITH INTRAVENOUS MODALINE SULFATE (W3207B), PSYCHOSOMATICS 6: 1 (1965).","journal-title":"PSYCHOSOMATICS"},{"key":"e_1_2_1_51_1","first-page":"423","volume":"3","year":"1966","unstructured":"Durell, J., American Handbook of Psychiatry 3: 423 (1966).","journal-title":"American Handbook of Psychiatry"},{"key":"e_1_2_1_52_1","unstructured":"Eiduson S. Biochemistry and Behaviour (1964)."},{"key":"e_1_2_1_53_1","first-page":"107","volume":"156","year":"1967","unstructured":"Eisenfeld, A. J., Journal of Pharmacology and Experimental Therapeutics 156: 107 (1967).","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"e_1_2_1_54_1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/213297a0","volume":"213","year":"1967","unstructured":"EISENFELD, A.J., INHIBITION OF EXTRANEURONAL METABOLISM OF NORADRENALINE IN ISOLATED HEART BY ADRENERGIC BLOCKING AGENTS, NATURE 213: 297 (1967).","journal-title":"NATURE"},{"key":"e_1_2_1_55_1","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1210\/jcem-17-5-608","volume":"17","year":"1957","unstructured":"ELMADJIAN, F, EXCRETION OF EPINEPHRINE AND NOREPINEPHRINE IN VARIOUS EMOTIONAL STATES, JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM 17: 608 (1957).","journal-title":"JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM"},{"key":"e_1_2_1_56_1","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0079-6123(08)60111-9","volume":"8","year":"1964","unstructured":"FALCK, B, Progress in Brain Research 8: 28 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_57_1","first-page":"384","volume":"1","year":"1965","unstructured":"FELDSTEIN, A, MAO INHIBITION AND ANTIDEPRESSANT ACTIVITY, INTERNATIONAL JOURNAL OF NEUROPSYCHIATRY 1: 384 (1965).","journal-title":"INTERNATIONAL JOURNAL OF NEUROPSYCHIATRY"},{"key":"e_1_2_1_58_1","first-page":"13","volume":"19","year":"1964","unstructured":"FRANKENHAEUSER, M, CATECHOLAMINE EXCRETION AND PERFORMANCE DURING STRESS, PERCEPTUAL AND MOTOR SKILLS 19: 13 (1964).","journal-title":"PERCEPTUAL AND MOTOR SKILLS"},{"key":"e_1_2_1_59_1","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1176\/ajp.119.9.843","volume":"119","year":"1963","unstructured":"FREEDMAN, D.X., PSYCHOTOMIMETIC DRUGS AND BRAIN BIOGENIC-AMINES, AMERICAN JOURNAL OF PSYCHIATRY 119: 843 (1963).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_60_1","first-page":"198","year":"1963","unstructured":"Freedman, D. X., EEG and Behavior: 198 (1963).","journal-title":"EEG and Behavior"},{"key":"e_1_2_1_61_1","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1097\/00005053-195405000-00002","volume":"119","year":"1954","unstructured":"FUNKENSTEIN, D.H., NOR-EPINEPHRINE-LIKE AND EPINEPHRINE-LIKE SUBSTANCES AND THE ELEVATION OF BLOOD PRESSURE DURING ACUTE STRESS, JOURNAL OF NERVOUS AND MENTAL DISEASE 119: 380 (1954).","journal-title":"JOURNAL OF NERVOUS AND MENTAL DISEASE"},{"key":"e_1_2_1_62_1","doi-asserted-by":"crossref","unstructured":"Funkenstein D. H. Mastery of Stress (1957).","DOI":"10.4159\/harvard.9780674332911"},{"key":"e_1_2_1_63_1","first-page":"74","volume":"192","year":"1955","unstructured":"Funkenstein, D. H., Scientific American 192:74 (1955).","journal-title":"Scientific American"},{"key":"e_1_2_1_64_1","unstructured":"Garattini S. Serotonin (1965)."},{"key":"e_1_2_1_65_1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archpsyc.1962.01710190098011","volume":"6","year":"1962","unstructured":"GERSHON, S, IMIPRAMINE HYDROCHLORIDE - ITS EFFECTS ON CLINICAL, AUTONOMIC, AND PSYCHOLOGICAL FUNCTIONS, ARCHIVES OF GENERAL PSYCHIATRY 6: 96 (1962).","journal-title":"ARCHIVES OF GENERAL PSYCHIATRY"},{"key":"e_1_2_1_66_1","first-page":"229","volume":"1","year":"1960","unstructured":"GERSHON, S, JOURNAL OF NEUROPSYCHIATRY 1: 229 (1960).","journal-title":"JOURNAL OF NEUROPSYCHIATRY"},{"key":"e_1_2_1_67_1","first-page":"301","volume":"1","year":"1958","unstructured":"GIARMAN, N.J., THE INTRACELLULAR DISTRIBUTION OF 5-HYDROXYTRYPTAMINE (HT SEROTONIN) IN THE RATS BRAIN, BIOCHEMICAL PHARMACOLOGY 1: 301 (1958).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_68_1","first-page":"73","volume":"132","year":"1959","unstructured":"GIARMAN, N.J., YALE JOURNAL OF BIOLOGY AND MEDICINE 132: 73 (1959).","journal-title":"YALE JOURNAL OF BIOLOGY AND MEDICINE"},{"key":"e_1_2_1_69_1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1471-4159.1965.tb10247.x","volume":"12","year":"1965","unstructured":"GLOWINSKI, J, METABOLISM OF [3H]NOREPINEPHRINE IN RAT BRAIN, JOURNAL OF NEUROCHEMISTRY 12: 25 (1965).","journal-title":"JOURNAL OF NEUROCHEMISTRY"},{"key":"e_1_2_1_70_1","first-page":"43","volume":"149","year":"1965","unstructured":"GLOWINSKI, J, EFFECT OF DRUGS ON UPTAKE RELEASE AND METABOLISM OF H3-NOREPINEPHRINE IN RAT BRAIN, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 149: 43 (1965).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_71_1","first-page":"385","volume":"151","year":"1966","unstructured":"GLOWINSKI, J, STORAGE AND SYNTHESIS OF NOREPINEPHRINE IN RESERPINE-TREATED RAT BRAIN, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 151: 385 (1966).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_72_1","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/2041318a0","volume":"204","year":"1964","unstructured":"GLOWINSKI, J, INHIBITION OF UPTAKE OF TRITIATED-NORADRENALINE IN INTACT RAT BRAIN BY IMIPRAMINE + STRUCTURALLY RELATED COMPOUNDS, NATURE 204: 1318 (1964).","journal-title":"NATURE"},{"key":"e_1_2_1_73_1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1172\/JCI104471","volume":"41","year":"1962","unstructured":"GOODALL, M, SYMPATHOADRENAL RESPONSE TO GRAVITATIONAL STRESS, JOURNAL OF CLINICAL INVESTIGATION 41: 197 (1962).","journal-title":"JOURNAL OF CLINICAL INVESTIGATION"},{"key":"e_1_2_1_74_1","unstructured":"Goodman L. S. The Pharmacological Bases of Therapeutics 2 (1955)."},{"key":"e_1_2_1_75_1","first-page":"150","year":"1964","unstructured":"Green, H., Biogenic Amines: 150 (1964).","journal-title":"Biogenic Amines"},{"key":"e_1_2_1_76_1","first-page":"225","volume":"3","year":"1960","unstructured":"GYERMEK, L, MED EXP BASEL 3: 225 (1960).","journal-title":"MED EXP BASEL"},{"key":"e_1_2_1_77_1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/j.1748-1716.1964.tb02897.x","volume":"60","year":"1964","unstructured":"HAGGENDAL, J, DISCLOSURE OF LABILE MONOAMINE FRACTIONS IN BRAIN + THEIR CORRELATION TO BEHAVIOUR, ACTA PHYSIOLOGICA SCANDINAVICA 60: 351 (1964).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_78_1","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/BF00404170","volume":"8","year":"1965","unstructured":"HANSSON, LCF, DISRUPTION OF CONDITIONED AVOIDANCE RESPONSE FOLLOWING SELECTIVE DEPLETION OF BRAIN CATECHOL AMINES, PSYCHOPHARMACOLOGIA 8: 100 (1965).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_79_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1176\/ajp.113.10.950","volume":"113","year":"1957","unstructured":"HARRIS, T.H., DEPRESSION INDUCED BY RAUWOLFIA COMPOUNDS, AMERICAN JOURNAL OF PSYCHIATRY 113: 950 (1957).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_80_1","first-page":"120","volume":"1","year":"1959","unstructured":"Havens, L. L., Biological Psychiatry 1: 120 (1959).","journal-title":"Biological Psychiatry"},{"key":"e_1_2_1_81_1","first-page":"40","volume":"12","year":"1960","unstructured":"HAWKINS, D.R., PSYCHIATRIC RESEARCH REPORTS 12: 40 (1960).","journal-title":"PSYCHIATRIC RESEARCH REPORTS"},{"key":"e_1_2_1_82_1","first-page":"146","volume":"134","year":"1961","unstructured":"HERTTING, G, EFFECT OF DRUGS ON UPTAKE AND METABOLISM OF H3-NOREPINEPHRINE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 134: 146 (1961).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_83_1","first-page":"727","volume":"18","year":"1966","unstructured":"HILLARP, N.A., DEMONSTRATION AND MAPPING OF CENTRAL NEURONS CONTAINING DOPAMINE NORADRENALINE AND 5-HYDROXYTRYPTAMINE AND THEIR REACTIONS TO PSYCHOPHARMACA, PHARMACOLOGICAL REVIEWS 18: 727 (1966).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_84_1","unstructured":"Himwich H. E. Progress in Brain Research 8 (1964)."},{"key":"e_1_2_1_85_1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0074-7742(08)60600-5","volume":"5","year":"1963","unstructured":"HOLMBERG, G, BIOLOGICAL ASPECTS OF ELECTROCONVULSIVE THERAPY, INTERNATIONAL REVIEW OF NEUROBIOLOGY 5: 389 (1963).","journal-title":"INTERNATIONAL REVIEW OF NEUROBIOLOGY"},{"key":"e_1_2_1_86_1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1471-4159.1956.tb12048.x","volume":"1","year":"1956","unstructured":"HOLZBAUER, M, DEPRESSION BY RESERPINE OF THE NORADRENALINE CONCENTRATION IN THE HYPOTHALAMUS OF THE CAT, JOURNAL OF NEUROCHEMISTRY 1: 8 (1956).","journal-title":"JOURNAL OF NEUROCHEMISTRY"},{"key":"e_1_2_1_87_1","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1056\/NEJM196506032722206","volume":"272","year":"1965","unstructured":"HORDERN, A, ANTIDEPRESSANT DRUGS, NEW ENGLAND JOURNAL OF MEDICINE 272: 1159 (1965).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_88_1","first-page":"173","volume":"150","year":"1965","unstructured":"IVERSEN, L.L., UPTAKE AND STORAGE OF H3-NOREPINEPHRINE IN RESERPINE-PRETREATED RAT HEART, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 150: 173 (1965).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_89_1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.2042-7158.1964.tb07488.x","volume":"16","year":"1964","unstructured":"IVERSEN, L.L., INHIBITION OF NORADRENALINE UPTAKE BY SYMPATHOMIMETIC AMINES, JOURNAL OF PHARMACY AND PHARMACOLOGY 16: 435 (1964).","journal-title":"JOURNAL OF PHARMACY AND PHARMACOLOGY"},{"key":"e_1_2_1_90_1","unstructured":"James W. Principles of Psychology (1990)."},{"key":"e_1_2_1_91_1","first-page":"1","year":"1956","unstructured":"KARKI, N. T., ACTA PHYSIOLOGICA SCANDINAVICA 39 1 (1956).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_92_1","first-page":"787","volume":"18","year":"1966","unstructured":"KETY, S.S., CATECHOLAMINES IN NEUROPSYCHIATRIC STATES, PHARMACOLOGICAL REVIEWS 18: 787 (1966).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_93_1","first-page":"311","year":"1962","unstructured":"Kety, S. S., Ultrastructure and Metabolism of the Nervous System: 311 (1962).","journal-title":"Ultrastructure and Metabolism of the Nervous System"},{"key":"e_1_2_1_94_1","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI102603","volume":"31","year":"1952","unstructured":"KING, B.D., THE EFFECTS OF L-EPINEPHRINE AND L-NOR-EPINEPHRINE UPON CEREBRAL CIRCULATION AND METABOLISM IN MAN, JOURNAL OF CLINICAL INVESTIGATION 31: 273 (1952).","journal-title":"JOURNAL OF CLINICAL INVESTIGATION"},{"key":"e_1_2_1_95_1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0022-3956(63)90004-9","volume":"1","year":"1963","unstructured":"KLERMAN, G.L., CLINICAL-EXPERIENCE WITH DIHYDROXYPHENYLALANINE (DOPA) IN DEPRESSION, JOURNAL OF PSYCHIATRIC RESEARCH 1: 289 (1963).","journal-title":"JOURNAL OF PSYCHIATRIC RESEARCH"},{"key":"e_1_2_1_96_1","first-page":"101","volume":"17","year":"1965","unstructured":"KLERMAN, G.L., CLINICAL PHARMCOLOGY OF IMIPRAMINE AND RELATED ANTIDEPRESSANT COMPOUNDS, PHARMACOLOGICAL REVIEWS 17: 101 (1965).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_97_1","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1176\/ajp.120.3.274","volume":"120","year":"1963","unstructured":"KLINE, N.S., RELIEF OF DEPRESSION WITHIN 1 DAY USING AN M.A.O. INHIBITOR AND INTRAVENOUS 5-HTP, AMERICAN JOURNAL OF PSYCHIATRY 120: 274 (1963).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_98_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1176\/ajp.121.4.379","volume":"121","year":"1964","unstructured":"KLINE, N.S., FURTHER-STUDIES ON - 1 DAY TREATMENT OF DEPRESSION WITH 5-HTP, AMERICAN JOURNAL OF PSYCHIATRY 121: 379 (1964).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_99_1","first-page":"218","year":"1959","unstructured":"Kline, N. S., The Effect of Pharmacologic Agents on the Nervous System: 218 (1959).","journal-title":"The Effect of Pharmacologic Agents on the Nervous System"},{"key":"e_1_2_1_100_1","first-page":"452","volume":"25","year":"1966","unstructured":"KOE, B.K., MARKED DEPLETION OF BRAIN SEROTONIN BY P-CHLOROPHENYLALANINE, FEDERATION PROCEEDINGS 25: 452 (1966).","journal-title":"FEDERATION PROCEEDINGS"},{"key":"e_1_2_1_101_1","first-page":"351","volume":"138","year":"1962","unstructured":"KOPIN, I.J., METABOLISM OF NOREPINEPHRINE-H-3 RELEASED BY TYRAMINE AND RESERPINE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 138: 351 (1962).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_102_1","first-page":"207","volume":"140","year":"1963","unstructured":"KOPIN, I.J., METABOLISM OF ADMINISTERED AND DRUG-RELEASED NOREPINEPHRINE-7-H3 IN RAT, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 140: 207 (1963).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_103_1","first-page":"179","volume":"16","year":"1964","unstructured":"KOPIN, I.J., STORAGE + METABOLISM OF CATECHOLAMINES - ROLE OF MONOAMINE OXIDASE, PHARMACOLOGICAL REVIEWS 16: 179 (1964).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_104_1","first-page":"513","volume":"18","year":"1966","unstructured":"KOPIN, I.J., BIOCHEMICAL ASPECTS OF RELEASE OF NOREPINEPHRINE AND OTHER AMINES FROM SYMPATHETIC NERVE ENDINGS, PHARMACOLOGICAL REVIEWS 18: 513 (1966).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_105_1","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1176\/ajp.115.5.459","volume":"115","year":"1958","unstructured":"KUHN, R, THE TREATMENT OF DEPRESSIVE STATES WITH G-22355 (IMIPRAMINE HYDROCHLORIDE), AMERICAN JOURNAL OF PSYCHIATRY 115: 459 (1958).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_106_1","first-page":"522","volume":"74","year":"1956","unstructured":"LEMIEUX, G, CAN MED ASSOC J 74: 522 (1956).","journal-title":"CAN MED ASSOC J"},{"key":"e_1_2_1_107_1","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/00006842-196501000-00009","volume":"27","year":"1965","unstructured":"LEVI, L, THE URINARY OUTPUT OF ADRENALINE AND NORADRENALIN DURING PLEASANT AND UNPLEASANT EMOTIONAL STATES - A PRELIMINARY-REPORT, PSYCHOSOMATIC MEDICINE 27: 80 (1965).","journal-title":"PSYCHOSOMATIC MEDICINE"},{"key":"e_1_2_1_108_1","doi-asserted-by":"crossref","unstructured":"Lewis G. P. 5-Hydroxytryptamine (1958).","DOI":"10.1111\/j.2042-7158.1958.tb10338.x"},{"key":"e_1_2_1_109_1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1097\/00006842-194007000-00001","volume":"2","year":"1940","unstructured":"LINDEMANN, E, PSYCHOSOM MED 2: 231 (1940).","journal-title":"PSYCHOSOM MED"},{"key":"e_1_2_1_110_1","first-page":"1","year":"1963","unstructured":"LINGJAERDE, O, ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA 170: 1 (1963).","journal-title":"ACTA PSYCHIATRICA ET NEUROLOGICA SCANDINAVICA"},{"key":"e_1_2_1_111_1","unstructured":"LIPTON M.A. PERSONAL COMMUNICATION."},{"issue":"8","key":"e_1_2_1_112_1","first-page":"129","year":"1957","unstructured":"LOOMER, H.P., PSYCHIATRIC RESEARCH REPORTS 8: 129 (1957).","journal-title":"PSYCHIATRIC RESEARCH REPORTS"},{"key":"e_1_2_1_113_1","first-page":"301","volume":"2","year":"1924","unstructured":"MARANON, G, REVUE FRANCAISE D'ENDOCRINOLOGIE 2: 301 (1924).","journal-title":"REVUE FRANCAISE D'ENDOCRINOLOGIE"},{"key":"e_1_2_1_114_1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/00006842-196107000-00011","volume":"23","year":"1961","unstructured":"MASON, J.W., CONCURRENT PLASMA EPINEPHRINE, NOREPINEPHRINE AND 17-HYDROXYCORTICOSTEROID LEVELS DURING CONDITIONED EMOTIONAL DISTURBANCES IN MONKEYS, PSYCHOSOMATIC MEDICINE 23: 344 (1961).","journal-title":"PSYCHOSOMATIC MEDICINE"},{"key":"e_1_2_1_115_1","unstructured":"MATUSSEK N PERSONAL COMMUNICATION."},{"key":"e_1_2_1_116_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/0022-3956(62)90007-9","volume":"1","year":"1962","unstructured":"MCDONALD, R.K., THE EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID IN NORMAL AND IN CHRONIC-SCHIZOPHRENIC MALE-SUBJECTS - EFFECT OF RESERPINE AND CHLORPROMAZINE, JOURNAL OF PSYCHIATRIC RESEARCH 1: 173 (1962).","journal-title":"JOURNAL OF PSYCHIATRIC RESEARCH"},{"key":"e_1_2_1_117_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archneur.1963.00460070091009","volume":"9","year":"1963","unstructured":"MCGEER, P.L., CENTRAL AROMATIC AMINE LEVELS AND BEHAVIOR .2. SEROTONIN AND CATECHOLAMINE LEVELS IN VARIOUS CAT BRAIN AREAS FOLLOWING ADMINISTRATION OF PSYCHOACTIVE DRUGS OR AMINE PRECURSORS, ARCHIVES OF NEUROLOGY 9: 81 (1963).","journal-title":"ARCHIVES OF NEUROLOGY"},{"key":"e_1_2_1_118_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archneur.1963.00460070091009","volume":"9","year":"1963","unstructured":"MCGEER, P, ARCHIVES OF NEUROLOGY 9: 81 (1963).","journal-title":"ARCHIVES OF NEUROLOGY"},{"key":"e_1_2_1_119_1","unstructured":"McLennan H. Synaptic Transmission (1963)."},{"key":"e_1_2_1_120_1","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/0006-2952(63)90196-5","volume":"12","year":"1963","unstructured":"MOORE, K.E., EFFECTS OF D-AMPHETAMINE AND RESTRAINT ON CONTENT OF NOREPINEPHRINE AND DOPAMINE IN RAT BRAIN, BIOCHEMICAL PHARMACOLOGY 12: 1283 (1963).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_121_1","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/0006-2952(64)90107-8","volume":"13","year":"1964","unstructured":"MOORE, K.E., EFFECTS OF STRESS + D-AMPHETAMINE ON RAT BRAIN CATECHOLAMINES, BIOCHEMICAL PHARMACOLOGY 13: 1098 (1964).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_122_1","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jama.1955.02960260006002","volume":"159","year":"1955","unstructured":"MULLER, J. C., JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION 159: 836 (1955).","journal-title":"JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION"},{"key":"e_1_2_1_123_1","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1037\/h0058775","volume":"47","year":"1954","unstructured":"OLDS, J, POSITIVE REINFORCEMENT PRODUCED BY ELECTRICAL STIMULATION OF SEPTAL AREA AND OTHER REGIONS OF RAT BRAIN, JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY 47: 419 (1954).","journal-title":"JOURNAL OF COMPARATIVE AND PHYSIOLOGICAL PSYCHOLOGY"},{"key":"e_1_2_1_124_1","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1152\/physrev.1962.42.4.554","volume":"42","year":"1962","unstructured":"OLDS, J, HYPOTHALAMIC SUBSTRATES OF REWARD, PHYSIOLOGICAL REVIEWS 42: 554 (1962).","journal-title":"PHYSIOLOGICAL REVIEWS"},{"key":"e_1_2_1_125_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/jnnp.22.3.247","volume":"22","year":"1959","unstructured":"PARE, CMB, A CLINICAL AND BIOCHEMICAL STUDY OF A TRIAL OF IPRONIAZID IN THE TREATMENT OF DEPRESSION, JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY 22: 247 (1959).","journal-title":"JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY"},{"key":"e_1_2_1_126_1","first-page":"527","volume":"2","year":"1963","unstructured":"PARE, CMB, POTENTIAITON OF MONOAMINE-OXIDASE INHIBITORS BY TRYPTOPHAN, LANCET 2: 527 (1963).","journal-title":"LANCET"},{"key":"e_1_2_1_127_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.122.3165.374"},{"key":"e_1_2_1_128_1","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/BF00408187","volume":"4","year":"1963","unstructured":"POLDINGER, W, COMBINED ADMINISTRATION OF DESIPRAMINE AND RESERPINE OR TETRABENAZINE IN DEPRESSIVE PATIENTS, PSYCHOPHARMACOLOGIA 4: 308 (1963).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_129_1","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0022-3956(61)90006-1","volume":"1","year":"1961","unstructured":"POLLIN, W, THE PHYSIOLOGICAL AND PSYCHOLOGICAL EFFECTS OF INTRAVENOUSLY ADMINISTERED EPINEPHRINE AND ITS METABOLISM IN NORMAL AND SCHIZOPHRENIC MEN .2. PSYCHIATRIC OBSERVATIONS, JOURNAL OF PSYCHIATRIC RESEARCH 1: 50 (1961).","journal-title":"JOURNAL OF PSYCHIATRIC RESEARCH"},{"key":"e_1_2_1_130_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.133.3446.104"},{"key":"e_1_2_1_131_1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0024-3205(63)90087-0","volume":"2","year":"1963","unstructured":"POSCHEL, BPH, LIFE SCI 2: 782 (1963).","journal-title":"LIFE SCI"},{"key":"e_1_2_1_132_1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0024-3205(64)90155-9","volume":"3","year":"1964","unstructured":"POSCHEL, BPH, EXCITATORY (ANTIDEPRESSANT QUESTIONABLE) EFFECTS OF MONOAMINE OXIDASE INHIBITORS ON THE REWARD SYSTEM OF THE BRAIN, LIFE SCIENCES 3: 903 (1964).","journal-title":"LIFE SCIENCES"},{"key":"e_1_2_1_133_1","first-page":"199","volume":"140","year":"1963","unstructured":"POTTER, L.T., STUDIES ON STORAGE OF NOREPINEPHRINE AND EFFECT OF DRUGS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 140: 199 (1963).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_134_1","first-page":"217","volume":"25","year":"1964","unstructured":"PRANGE, A.J., PHARMACOLOGY + BIOCHEMISTRY OF DEPRESSION, DISEASES OF THE NERVOUS SYSTEM 25: 217 (1964).","journal-title":"DISEASES OF THE NERVOUS SYSTEM"},{"key":"e_1_2_1_135_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.149.3682.450"},{"key":"e_1_2_1_136_1","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/003591574003301001","volume":"33","year":"1940","unstructured":"RICHTER, D, PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE 33: 615 (1940).","journal-title":"PROCEEDINGS OF THE ROYAL SOCIETY OF MEDICINE"},{"key":"e_1_2_1_137_1","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archpsyc.1965.01730060013002","volume":"13","year":"1965","unstructured":"ROSENBLATT, S, DIFFERENCES IN METABOLISM OF NOREPINEPHRINE IN DEPRESSIONS, ARCHIVES OF GENERAL PSYCHIATRY 13: 495 (1965).","journal-title":"ARCHIVES OF GENERAL PSYCHIATRY"},{"key":"e_1_2_1_138_1","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1471-4159.1960.tb13350.x","volume":"5","year":"1960","unstructured":"ROSENBLATT, S, INTERRELATIONSHIPS BETWEEN ELECTROSHOCK, THE BLOOD-BRAIN BARRIER, AND CATECHOLAMINES, JOURNAL OF NEUROCHEMISTRY 5: 172 (1960).","journal-title":"JOURNAL OF NEUROCHEMISTRY"},{"key":"e_1_2_1_139_1","first-page":"494","volume":"11","year":"1959","unstructured":"ROTHBALLER, A.B., THE EFFECTS OF CATECHOLAMINES ON THE CENTRAL NERVOUS SYSTEM, PHARMACOLOGICAL REVIEWS 11: 494 (1959).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_140_1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1476-5381.1961.tb01121.x","volume":"17","year":"1961","unstructured":"RYALL, R.W., EFFECTS OF COCAINE AND ANTIDEPRESSANT DRUGS ON NICTITATING MEMBRANE OF CAT, BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY 17: 339 (1961).","journal-title":"BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY"},{"key":"e_1_2_1_141_1","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/h0046234","volume":"69","year":"1962","unstructured":"SCHACHTER, S, COGNITIVE, SOCIAL, AND PHYSIOLOGICAL DETERMINANTS OF EMOTIONAL STATE, PSYCHOLOGICAL REVIEW 69: 379 (1962).","journal-title":"PSYCHOLOGICAL REVIEW"},{"key":"e_1_2_1_142_1","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0006-2952(62)90073-4","volume":"11","year":"1962","unstructured":"SCHANBERG, S.M., DRUG-INDUCED ALTERATIONS IN SUB-CELLULAR DISTRIBUTION OF 5-HYDROXYTRYPTAMINE IN RATS BRAIN, BIOCHEMICAL PHARMACOLOGY 11: 187 (1962).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_143_1","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-2952(67)90040-8","volume":"16","year":"1967","unstructured":"SCHANBERG, S.M., EFFECTS OF PSYCHOACTIVE DRUGS ON NOREPINEPHRINE-3H METABOLISM IN BRAIN, BIOCHEMICAL PHARMACOLOGY 16: 393 (1967).","journal-title":"BIOCHEMICAL PHARMACOLOGY"},{"key":"e_1_2_1_144_1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00413242","volume":"5","year":"1964","unstructured":"SCHECKEL, C.L., BEHAVIORAL-EFFECTS OF INTERACTING IMIPRAMINE AND OTHER DRUGS WITH D-AMPHETAMINE, COCAINE, AND TETRABENAZINE, PSYCHOPHARMACOLOGIA 5: 198 (1964).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_145_1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","volume":"122","year":"1965","unstructured":"SCHILDKRAUT, J.J., THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE-DISORDERS - A REVIEW OF SUPPORTING EVIDENCE, AMERICAN JOURNAL OF PSYCHIATRY 122: 509 (1965).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_146_1","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1176\/ajp.123.6.690","volume":"123","year":"1966","unstructured":"SCHILDKRAUT, J.J., NORMETANEPHRINE EXCRETION AND AFFECTIVE STATE IN DEPRESSED PATIENTS TREATED WITH IMIPRAMINE, AMERICAN JOURNAL OF PSYCHIATRY 123: 690 (1966).","journal-title":"AMERICAN JOURNAL OF PSYCHIATRY"},{"key":"e_1_2_1_147_1","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/j.1749-6632.1963.tb13344.x","volume":"107","year":"1963","unstructured":"SCHILDKRAUT, J.J., BIOCHEMICAL AND PRESSOR EFFECTS OF ORAL D,L-DIHYDROXYPHENYLALANINE IN PATIENTS PRETREATED WITH ANTIDEPRESSANT DRUGS, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 107: 1005 (1963).","journal-title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES"},{"key":"e_1_2_1_148_1","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0022-3956(64)90012-3","volume":"2","year":"1964","unstructured":"SCHILDKRAUT, J.J., EXCRETION OF 3-METHOXY-4-HYDROXYMANDELIC ACID (VMA) IN DEPRESSED-PATIENTS TREATED WITH ANTIDEPRESSANT DRUGS, JOURNAL OF PSYCHIATRIC RESEARCH 2: 257 (1964).","journal-title":"JOURNAL OF PSYCHIATRIC RESEARCH"},{"key":"e_1_2_1_149_1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0022-3956(65)90003-8","volume":"3","year":"1965","unstructured":"SCHILDKRAUT, J.J., CATECHOLAMINE METABOLISM IN AFFECTIVE-DISORDERS .1. NORMETANEPHRINE AND VMA EXCRETION IN DEPRESSED-PATIENTS TREATED WITH IMIPRAMINE, JOURNAL OF PSYCHIATRIC RESEARCH 3: 213 (1965).","journal-title":"JOURNAL OF PSYCHIATRIC RESEARCH"},{"key":"e_1_2_1_150_1","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/0024-3205(66)90221-9","volume":"5","year":"1966","unstructured":"SCHILDKRAUT, J.J., LIFE SCI 5: 1479 (1966).","journal-title":"LIFE SCI"},{"key":"e_1_2_1_151_1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0079-6123(08)60128-4","volume":"8","year":"1964","unstructured":"SCHOPBACH, R.R., Progress in Brain Research 8: 207 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_152_1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/BF00408113","volume":"1","year":"1959","unstructured":"SCHOU, M, LITHIUM IN PSYCHIATRIC THERAPY - STOCK-TAKING AFTER 10 YEARS, PSYCHOPHARMACOLOGIA 1: 65 (1959).","journal-title":"PSYCHOPHARMACOLOGIA"},{"key":"e_1_2_1_153_1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1748-1716.1965.tb04175.x","volume":"64","year":"1965","unstructured":"SEDVALL, G, ADRENERGIC TRANSMISSION AT VASOCONSTRICTOR NERVE TERMINALS PARTIALLY DEPLETED OF NORADRENALINE, ACTA PHYSIOLOGICA SCANDINAVICA 64: 251 (1965).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_154_1","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/j.1552-4604.1964.tb00358.x","volume":"4","year":"1964","unstructured":"SHAFFER, J.W., J NEW DRUGS 4: 288 (1964).","journal-title":"J NEW DRUGS"},{"key":"e_1_2_1_155_1","first-page":"109","volume":"5","year":"1961","unstructured":"SHINFUKU, N, CATECHOL AMINES EXCRETION IN MANIC DEPRESSIVE PSYCHOSIS, YONAGO ACTA MEDICA 5: 109 (1961).","journal-title":"YONAGO ACTA MEDICA"},{"key":"e_1_2_1_156_1","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1749-6632.1957.tb40751.x","volume":"66","year":"1957","unstructured":"SHORE, P.A., ROLE OF BRAIN SEROTONIN IN RESERPINE ACTION, ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 66: 609 (1957).","journal-title":"ANNALS OF THE NEW YORK ACADEMY OF SCIENCES"},{"key":"e_1_2_1_157_1","first-page":"531","volume":"14","year":"1962","unstructured":"SHORE, P.A., RELEASE OF SEROTONIN AND CATECHOLAMINES BY DRUGS, PHARMACOLOGICAL REVIEWS 14: 531 (1962).","journal-title":"PHARMACOLOGICAL REVIEWS"},{"key":"e_1_2_1_158_1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/070674375900401S07","volume":"4","year":"1959","unstructured":"SIGG, E.B., CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL 4: 75 (1959).","journal-title":"CANADIAN PSYCHIATRIC ASSOCIATION JOURNAL"},{"key":"e_1_2_1_159_1","first-page":"13","volume":"142","year":"1963","unstructured":"SIGG, E.B., INFLUENCE OF IMIPRAMINE AND RELATED PSYCHOACTIVE AGENTS ON EFFECT OF 5-HYDROXYTRYPTAMINE AND CATECHOLAMINES ON CAT NICTITATING MEMBRANE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 142: 13 (1963).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_160_1","first-page":"16","volume":"12","year":"1960","unstructured":"SILVERMAN, A.J., PSYCHIATRIC RESEARCH REPORTS 12: 16 (1960).","journal-title":"PSYCHIATRIC RESEARCH REPORTS"},{"key":"e_1_2_1_161_1","first-page":"104","volume":"3","year":"1961","unstructured":"SILVERMAN, A.J., RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY 3: 104 (1961).","journal-title":"RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY"},{"key":"e_1_2_1_162_1","first-page":"159","volume":"2","year":"1958","unstructured":"SJOERDMA, A, A SIMPLE METHOD FOR THE MEASUREMENT OF MONOAMINE-OXIDASE INHIBITION IN MAN, LANCET 2: 159 (1958).","journal-title":"LANCET"},{"key":"e_1_2_1_163_1","first-page":"1092","volume":"2","year":"1965","unstructured":"SJOERDSMA, A, INHIBITION OF CATECHOLAMINE SYNTHESIS IN MAN WITH ALPHA-METHYL-TYROSINE AN INHIBITOR OF TYROSINE HYDROXYLASE, LANCET 2: 1092 (1965).","journal-title":"LANCET"},{"key":"e_1_2_1_164_1","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1056\/NEJM196212272672603","volume":"267","year":"1962","unstructured":"SMITH, B, CENTRAL-NERVOUS-SYSTEM EFFECTS OF INGESTION OFL-TRYPTOPHAN BY NORMAL SUBJECTS, NEW ENGLAND JOURNAL OF MEDICINE 267: 1338 (1962).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_165_1","first-page":"343","volume":"142","year":"1963","unstructured":"SMITH, C.B., ENHANCEMENT BY RESERPINE AND ALPHA-METHYL DOPA OF EFFECTS OF DELTA-AMPHETAMINE UPON LOCOMOTOR ACTIVITY OF MICE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 142: 343 (1963).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_166_1","first-page":"96","volume":"147","year":"1965","unstructured":"SMITH, C.B., EFFECTS OF D-AMPHETAMINE UPON BRAIN AMINE CONTENT AND LOCOMOTOR ACTIVITY OF MICE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 147: 96 (1965).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_167_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/0028-3908(63)90037-6","volume":"2","year":"1963","unstructured":"SPECTOR, S, ASSOCIATION OF BEHAVIOURAL EFFECTS OF PARGYLINE, A NON-HYDRAZIDE MAO INHIBITOR WITH INCREASE IN BRAIN NOREPINEPHRINE, INTERNATIONAL JOURNAL OF NEUROPHARMACOLOGY 2: 81 (1963).","journal-title":"INTERNATIONAL JOURNAL OF NEUROPHARMACOLOGY"},{"key":"e_1_2_1_168_1","first-page":"15","volume":"128","year":"1960","unstructured":"SPECTOR, S, BIOCHEMICAL AND PHARMACOLOGICAL EFFECTS OF THE MONOAMINE OXIDASE INHIBITORS, IPRONIAZID, 1-PHENYL-2-HYDRAZINOPROPANE(JB 516) AND 1-PHENYL-3-HYDRAZINOBUTANE(JB 835), JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 128: 15 (1960).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_169_1","first-page":"86","volume":"147","year":"1965","unstructured":"SPECTOR, S, BLOCKADE OF ENDOGENOUS NOREPINEPHRINE SYNTHESIS BY ALPHA-METHYL-TYROSINE AN INHIBITOR OF TYROSINE HYDROXYLASE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 147: 86 (1965).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_170_1","unstructured":"Stein L. Antidepressant Drugs (1967)."},{"key":"e_1_2_1_171_1","first-page":"836","volume":"23","year":"1964","unstructured":"STEIN, L, SELF-STIMULATION OF BRAIN + CENTRAL STIMULANT ACTION OF AMPHETAMINE, FEDERATION PROCEEDINGS 23: 836 (1964).","journal-title":"FEDERATION PROCEEDINGS"},{"key":"e_1_2_1_172_1","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/1881199a0","volume":"188","year":"1960","unstructured":"STEIN, L, ACCELERATED RECOVERY FROM RESERPINE DEPRESSION BY MONOAMINE OXIDASE INHIBITORS, NATURE 188: 1199 (1960).","journal-title":"NATURE"},{"key":"e_1_2_1_173_1","first-page":"297","year":"1962","unstructured":"Stein, L., Psychosomatic Medicine: 297 (1962).","journal-title":"Psychosomatic Medicine"},{"key":"e_1_2_1_174_1","first-page":"288","volume":"4","year":"1962","unstructured":"STEIN, L, RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY 4: 288 (1962).","journal-title":"RECENT ADVANCES IN BIOLOGICAL PSYCHIATRY"},{"key":"e_1_2_1_175_1","first-page":"113","year":"1964","unstructured":"Stein, L., The Role of Pleasure in Behavior: 113 (1964).","journal-title":"The Role of Pleasure in Behavior"},{"key":"e_1_2_1_176_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.134.3474.286"},{"key":"e_1_2_1_177_1","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1192\/bjp.104.436.696","volume":"104","year":"1958","unstructured":"STROMOLSEN, R, HUMORAL CHANGES IN MANIC-DEPRESSIVE PSYCHOSIS WITH PARTICULAR REFERENCE TO THE EXCRETION OF CATECHOL AMINES IN URINE, JOURNAL OF MENTAL SCIENCE 104: 696 (1958).","journal-title":"JOURNAL OF MENTAL SCIENCE"},{"key":"e_1_2_1_178_1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.3109\/00365515909060440","volume":"11","year":"1959","unstructured":"STUDNITZ, W, J CLIN LAB INVEST 11: 224 (1959).","journal-title":"J CLIN LAB INVEST"},{"key":"e_1_2_1_179_1","first-page":"321","volume":"144","year":"1964","unstructured":"SULSER, F, ACTION OF DESMETHYLIMIPRAMINE IN COUNTERACTING SEDATION + CHOLINERGIC EFFECTS OF RESERPINE-LIKE DRUGS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 144: 321 (1964).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_180_1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1136\/bmj.1.4766.1003","volume":"1","year":"1952","unstructured":"SWAN, H. J. C., BRITISH MEDICAL JOURNAL 1: 1003 (1952).","journal-title":"BRITISH MEDICAL JOURNAL"},{"key":"e_1_2_1_181_1","first-page":"405","volume":"144","year":"1964","unstructured":"THOENEN, H, MODE OF ACTION OF IMIPRAMINE + 5-(3]-METHYLAMINOPROPYLIDEN)-DIBENZO)A,E)CYCLOHEPTA)1,3,5)TRIEN HYDROCHLORIDE )RO 4-6011), NEW ANTIDEPRESSANT DRUG ON PERIPHERAL ADRENERGIC MECHANISMS, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 144: 405 (1964).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_182_1","first-page":"538","volume":"25","year":"1964","unstructured":"TURNER, W, CLINICAL-TRIAL OF PARGYLINE + DOPA IN PSYCHOTIC SUBJECTS, DISEASES OF THE NERVOUS SYSTEM 25: 538 (1964).","journal-title":"DISEASES OF THE NERVOUS SYSTEM"},{"key":"e_1_2_1_183_1","unstructured":"Udenfriend S. 5-Hydroxytryptamine (1958)."},{"key":"e_1_2_1_184_1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02148316","volume":"18","year":"1962","unstructured":"VANROSSUM, J.M., MECHANISM OF ACTION OF COCAINE AND AMPHETAMINE IN BRAIN, EXPERIENTIA 18: 229 (1962).","journal-title":"EXPERIENTIA"},{"key":"e_1_2_1_185_1","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1113\/jphysiol.1954.sp005064","volume":"123","year":"1954","unstructured":"VOGT, M, JOURNAL OF PHYSIOLOGY-LONDON 123: 451 (1954).","journal-title":"JOURNAL OF PHYSIOLOGY-LONDON"},{"key":"e_1_2_1_186_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1748-1716.1954.tb01107.x","volume":"31","year":"1954","unstructured":"VONEULER, U.S., ADRENALINE AND NORADRENALINE OUTPUT IN URINE AFTER UNILATERAL AND BILATERAL ADRENALECTOMY IN MAN, ACTA PHYSIOLOGICA SCANDINAVICA 31: 1 (1954).","journal-title":"ACTA PHYSIOLOGICA SCANDINAVICA"},{"key":"e_1_2_1_187_1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/cpt196454398","volume":"5","year":"1964","unstructured":"VONEULER, U.S., QUANTITATION OF STRESS BY CATECHOLAMINE ANALYSIS, CLINICAL PHARMACOLOGY & THERAPEUTICS 5: 398 (1964).","journal-title":"CLINICAL PHARMACOLOGY & THERAPEUTICS"},{"key":"e_1_2_1_188_1","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1152\/jappl.1954.6.9.551","volume":"6","year":"1954","unstructured":"VONEULER, U.S., EFFECT OF FLYING ON THE EPINEPHRINE EXCRETION IN AIR FORCE PERSONNEL, JOURNAL OF APPLIED PHYSIOLOGY 6: 551 (1954).","journal-title":"JOURNAL OF APPLIED PHYSIOLOGY"},{"key":"e_1_2_1_189_1","unstructured":"von Euler U. S. Mechanisms of Release of Biogenic Amines (1966)."},{"key":"e_1_2_1_190_1","doi-asserted-by":"crossref","unstructured":"von Euler U. S. Noradrenaline (1956).","DOI":"10.1213\/00000539-195607000-00021"},{"key":"e_1_2_1_191_1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/archneur.1963.00460070079008","volume":"9","year":"1963","unstructured":"WADA, J.A., CENTRAL AROMATIC AMINE LEVELS AND BEHAVIOR .1. CONDITIONED AVOIDANCE RESPONSE IN CATS, FOLLOWING ADMINISTRATION OF PSYCHOACTIVE DRUGS OR AMINE PRECURSORS, ARCHIVES OF NEUROLOGY 9: 69 (1963).","journal-title":"ARCHIVES OF NEUROLOGY"},{"key":"e_1_2_1_192_1","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1001\/archinte.1919.00090260002001","volume":"24","year":"1919","unstructured":"WEARN, J.T., Studies on epinephrin. I Effects of the injection of epinephrin in soldiers with \"irritable heart\", ARCHIVES OF INTERNAL MEDICINE 24: 247 (1919).","journal-title":"ARCHIVES OF INTERNAL MEDICINE"},{"key":"e_1_2_1_193_1","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1192\/bjp.101.422.156","volume":"101","year":"1955","unstructured":"WEILMALHERBE, H, THE EFFECT OF CONVULSIVE THERAPY ON PLASMA ADRENALINE AND NORADRENALINE, JOURNAL OF MENTAL SCIENCE 101: 156 (1955).","journal-title":"JOURNAL OF MENTAL SCIENCE"},{"key":"e_1_2_1_194_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.129.3357.1226"},{"key":"e_1_2_1_195_1","first-page":"339","volume":"151","year":"1966","unstructured":"WEISSMAN, A, ANTIAMPHETAMINE EFFECTS FOLLOWING INHIBITION OF TYROSINE HYDROXYLASE, JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 151: 339 (1966).","journal-title":"JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS"},{"key":"e_1_2_1_196_1","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/0024-3205(65)90223-7","volume":"4","year":"1965","unstructured":"WEISSMAN, A, LIFE SCI 4: 1037 (1965).","journal-title":"LIFE SCI"},{"key":"e_1_2_1_197_1","first-page":"60","volume":"3","year":"1961","unstructured":"WEISSMAN, A, PHARMACOLOGIST 3: 60 (1961).","journal-title":"PHARMACOLOGIST"},{"key":"e_1_2_1_198_1","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0079-6123(08)60120-X","volume":"8","year":"1964","unstructured":"WHITTAKER, V.P., Progress in Brain Research 8: 90 (1964).","journal-title":"Progress in Brain Research"},{"key":"e_1_2_1_199_1","unstructured":"Woolley D. W. The Biochemical Bases of Psychoses or the Serotinin Hypothesis about Mental Diseases (1962)."},{"key":"e_1_2_1_200_1","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJM196509162731205","volume":"273","year":"1965","unstructured":"WURTMAN, R.J., MEDICAL PROGRESS - CATECHOLAMINES, NEW ENGLAND JOURNAL OF MEDICINE 273: 637 (1965).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_201_1","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM196509232731306","volume":"273","year":"1965","unstructured":"WURTMAN, R.J., CATECHOLAMINES (CONTINUED), NEW ENGLAND JOURNAL OF MEDICINE 273: 693 (1965).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_202_1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1056\/NEJM196509302731406","volume":"273","year":"1965","unstructured":"WURTMAN, R.J., CATHECHOLAMINES (CONCLUDED), NEW ENGLAND JOURNAL OF MEDICINE 273: 746 (1965).","journal-title":"NEW ENGLAND JOURNAL OF MEDICINE"},{"key":"e_1_2_1_203_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.150.3702.1464"}],"container-title":["Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/science.156.3771.21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,11]],"date-time":"2025-01-11T04:50:51Z","timestamp":1736571051000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/science.156.3771.21"}},"subtitle":["Pharmacological studies suggest a relationship between brain biogenic amines and affective state."],"short-title":[],"issued":{"date-parts":[[1967,4,7]]},"references-count":203,"journal-issue":{"issue":"3771","published-print":{"date-parts":[[1967,4,7]]}},"alternative-id":["10.1126\/science.156.3771.21"],"URL":"https:\/\/doi.org\/10.1126\/science.156.3771.21","relation":{},"ISSN":["0036-8075","1095-9203"],"issn-type":[{"value":"0036-8075","type":"print"},{"value":"1095-9203","type":"electronic"}],"subject":[],"published":{"date-parts":[[1967,4,7]]}}}